Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro

Citation
R. Brew et al., Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro, CYTOKINE, 12(1), 2000, pp. 78-85
Citations number
41
Categorie Soggetti
Cell & Developmental Biology
Journal title
CYTOKINE
ISSN journal
10434666 → ACNP
Volume
12
Issue
1
Year of publication
2000
Pages
78 - 85
Database
ISI
SICI code
1043-4666(200001)12:1<78:IAAAGF>2.0.ZU;2-Q
Abstract
Cell lines derived from human colon carcinomas secrete interleukin 8 (IL-8) in vitro and this chemokine has also been detected immunohistochemically i n human colon carcinoma specimens, in which it is tumour cell associated. I n these experiments, IL-8 was shown to comprise an important component of t he angiogenic activity of colon carcinoma cell line supernatants, The effec t of modulating IL-8 activity upon the growth of the colon carcinoma cell l ines HCT116A, HT29 and CaCo2 was investigated. Supplementing endogenously p roduced IL-8 by recombinant chemokine led to stimulation of cell growth. Ne utralization of the effect of endogenously produced IL-8, either with the s pecific antagonist peptide AcRRWWCR or with blocking anti-IL-8 antibody, re sulted in around 50% inhibition of cell growth (P<0.05). All of the colon c arcinoma cell lines tested expressed mRNA for both IL-8RA and RB when grown at:confluence. At the protein level, all cell lines expressed IL-8RA, Expr ession of IL-8RB was weak, although increased expression was seen in HCT116 A cells as they approached confluence, Antibodies to IL-8RA and RE did not affect proliferation at low cell density but were strongly inhibitory when cells were cultured at a higher density. These data suggest that IL-8 acts as an autocrine growth factor for colon carcinoma cell lines and would supp ort the concept that a similar autocrine loop operates in vivo. (C) 2000 Ac ademic Press.